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Factors Promoting or Preventing Caregivers from Allowing Pediatric
Participation in Research

Introduction
In recent years, participation in clinical research has greatly
influenced the prevention, prognosis, and treatment of many complex
diseases. Although study purpose, protocol, and personal incentives
influence enrollment in clinical studies, the greatest motivators for
participation are the advancement of knowledge and the altruistic hope of
finding an effective medical treatment.1 Unfortunately, relatively low
enrollment ranging from 3% to 20% has been reported for clinical trials for
certain chronic conditions such as cancer.2
Although awareness of the benefits of and opportunities afforded by
clinical trials has increased in the population, this awareness is far from
ubiquitous and reflects poor inclusion of racial/ethnic minorities, women,
and children.3 Among racial/ethnic minorities, study designs, cultural
differences, and linguistic barriers appear to limit participation, whereas the
opportunity for medical treatment seems to increase willingness to engage
in clinical studies.2,4 Assuming that minorities will not participate in a clinical
study has been shown to be a barrier for recruitment that lessens
participation and representation of underserved individuals in clinical
research.5,6 Pediatric clinical research has improved during recent years,
giving equal importance to common and uncommon diseases, designing
studies to address potential differences across a spectrum of ages, and
requiring participants’ assent and parental consent.7 The likelihood of a
child participating in a clinical trial is mostly independent of the child’s
willingness to participate; children’s lack of autonomy obliges parental
involvement, which is concurrently conditional to parental understanding,
trust, and endorsement of the research study. Given the trajectory of
children’s health into adulthood and the need to improve the health of the
next generation, pediatric inclusion in the development of evidence-based
medicine and therapies is paramount. From this perspective, this study
identified potential predictors for allowing children to participate in clinical
studies and evaluated whether motivators that promote or prevent parental
support of children’s participation differed according to racial/ethnic
categorization.
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Methods
Study Design and Participants
A sample of residents in South Florida’s Miami-Dade, Broward, and
Palm Beach counties was surveyed via landline or cell phone by
Professional Research Consultants Inc. (PRC). For the telephoneadministered survey, PRC assigned a caller ID number that was local to the
area, made multiple attempts to reach respondents, and called at different
times of the day on different days of the week. The sample was stratified by
county to ensure adequate representation among all strata. At the time of
the interview, for households with multiple children age 0–18, one child was
selected at random based on which had the most recent birthday, and the
survey questions were asked about that specific child. This produced a
sample that is more representative by demographics of age and gender.
The survey respondents were adults age 18 and older who had at least 1
child residing in the household for whom the respondent was the health care
decision-maker (child’s caregiver).
A sample of 1057 caregivers (the complete sample of the Community
Health Needs Assessment, CHNA) were included in the study, and
participants self-identified as Non-Hispanic White (n=406), Non-Hispanic
Black (n=177), Hispanic (n=398), Non-Hispanic Asian (n=30), and others
(n=18). Caregivers were 27.1% male (n=284) and 72.9% female (n=764).
Data were de-identified prior to the investigator receiving the data, and an
Institutional Review Board-exempt research protocol was approved for this
study.
Survey Methods
The survey interview was constructed as part of a broader CHNA
effort by a range of community stakeholders in child health in the South
Florida region, including health care systems, city departments, health
insurance companies, and school districts. For this research, we conducted
a secondary analysis of CHNA data. Survey questions pertained to health
care access, health insurance, chronic conditions, care utilization,
demographics of the child of interest, and demographics of the respondent.
To preserve generalizability of the responses, terms such as “clinical trial”
were defined during the administration of the questionnaire. After
nonresponse weights were taken into account, the data were post-stratified
based on sample characteristics of age, gender, race, ethnicity, and poverty
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status to further align the survey responses to known proportions in the
population using U.S. Census Bureau population estimates. A statistical
application package applied weighting variables that produced a sample.
While the integrity of each individual’s responses is maintained, 1
respondent’s responses may contribute to the whole the same weight as,
for example, 1.1 respondents. Another respondent, whose demographic
characteristics may have been slightly oversampled, may contribute the
same weight as 0.9 respondents.
Outcomes of Interest
Participants were asked, “In general, how likely would you be to allow
your child to participate in a clinical research trial?” with the answer options
being “Not at All Likely,” “Somewhat Likely,” or “Very Likely.” This question
was followed by either, “What is the MAIN reason you would allow your child
to participate in a clinical research trial?” or “What is the main reason you
would NOT allow your child to participate in a clinical research trial?” These
questions were open ended, meaning that respondents were free to say
whatever came to mind, and their verbatim responses were recorded.
These responses were then grouped thematically for the analysis. For those
not allowing participation, responses were classified into: “Fear or concern
over study,” “Need more information to decide,” “Inconvenience,” “Potential
lack of health benefit,” “Other,” or “Don’t know/Not sure.” For those allowing
participation, responses were classified as “Current health,” “Future health,”
“Science,” “Other,” or “Unsure.” These classifications were used to
understand the motivators that promote or prevent allowing participation,
whereas data from the other survey questions were used to identify
predictors for allowing participation.
Analytic Approach
Initial data preparation required the evaluation of item-level
nonresponse that, although limited for any one variable, could have been
more substantial in multivariate models. A machine learning approach to
variable multiple imputation was used to address item-level nonresponse
utilizing random forest imputation8,9. This approach accommodates the wide
number of potential interactions among covariates that may explain itemlevel nonresponse. Descriptive statistics were obtained for demographic
variables through percentages and 95% confidence intervals (CI).10
Unweighted and weighted responses for the question regarding the
willingness of participation in a clinical research trial and reasons to
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participate or not also were described in percentages and 95% CI for the
weighted estimates. We also evaluated whether reasons for allowing and
not allowing participation varied by race using weighted chi-square
analyses.
Preliminary identification of predictors for pediatric research
participation in clinical trials was achieved by performing exploratory
unadjusted weighted multinomial association tests between the outcome of
interest and a range of possibly related factors from the survey that may
have influenced participation. An associated group of predictors were
identified based on statistical associations at p < .10 and/or based on
theoretical relevance. These predictors included the child’s age, sex,
race/ethnicity categorization, insurance status, survey items capturing
whether the child had difficulties accessing health care, whether the child
was reported to be limited in ability to engage in normal activities due to any
condition, survey items capturing whether the child has ever had a chronic
condition, whether the child has ever needed a specialist, whether the child
needed special therapy or medication for any condition, the child’s weight
status (underweight, normal weight, overweight), household’s poverty
status, household language most predominantly used, and respondent’s
education level. Body mass index (BMI) was used to assess weight status,
and the BMI number was plotted on the CDC BMI-for-age growth charts to
obtain a percentile ranking. Percentiles were used to classify the weight
status as: underweight <5th percentile, healthy weight 5th and <85th
percentile, overweight 85th and <95th percentile, and obese 95th
percentile.
Preliminarily identified predictors were incorporated into a weighted
multivariable multinomial logistic model (full model). Rather than including
all identified covariates capturing information about access to care and
child’s health, 2 continuous sum score variables were derived. A “difficulties
in access to care” score was constructed by summing difficulties
experienced in the past 12 months (1=Yes, 0=No) among (a) difficulty
finding a physician to care for the child, (b) difficulty finding an appointment
for care, (c) difficulty finding available hours for care, (d) difficulty finding
transportation for care, (e) difficulty paying for the cost of care, and (f)
difficulty in the cost of medications. The reported chronic conditions sum
score was constructed by summing the respondents’ reports that the child
had ever suffered from or been diagnosed with the following: (a) food
allergies, (b) skin allergies, (c) respiratory allergies, (d) asthma, (e) a brain
injury or concussion, (f) diabetes, (g) 3 or more ear infections, (h) epilepsy,
(i) eye problems that could not be corrected with glasses or contact lenses,
(j) hearing problems, (k) a learning disability, or (l) a migraine.

https://digitalcommons.library.tmc.edu/childrenatrisk/vol11/iss1/6

4

Fernández et al.: Factors influencing children’s participation in research

Because of the limits in sample size, the covariates included in the
full model were further restricted into a reduced multivariable multinomial
model containing only those that showed evidence of a statistically marginal
or lower p-value (p < .10). All statistical analyses were performed using R
3.3 software.
Results
Table 1 shows weighted proportions and 95% CI for background
demographic variables. Table 2 provides unweighted and weighted
percentages according to how likely respondents were to allow a child to
participate in a clinical research trial. About 2% of participants (n=18)
reported they were unsure about participation or refused to provide an
answer to the question. These responses were considered missing and
imputed in weighted analyses to limit covariate categories with small
frequencies included in models. Unweighted proportions were within the
95% CI of weighted proportions, suggesting limited extreme changes during
sample weighting adjustments.
Table 3 shows unweighted and weighted descriptive information
about reasons that caregivers reported would influence their decision to
allow their children to participate in clinical research. Among the responders
who were very likely to allow their child to participate in research, the
majority chose “other” as their reason for participation, particularly if their
child was in excellent health. Some of the reasons categorized by “other”
were: “don’t know/not sure,” “purpose of research,” “money,” “safety,” “if
child would want to do it,” “depends on how it is done,” “availability of new
medications,” and “if appropriate for age.” The most common responses for
the selection “other” included “believe it is a good idea” and “depends on
the purpose of the research.” For responders who were unlikely to allow
their child to participate in clinical research, the most common response
was “fear/concern over study,” while the least likely reason was
“inconvenience.” The classification “fear/concern over study” included
specific responses such as “unknown side effects,” “no trust,” “child is too
young,” “unethical,” “painful,” “not FDA approved,” “unhealthy,” and “not
going to use my child as guinea pig.” Specific responses grouped under
“inconvenience” included “scheduling” and “lack of time.” Weighted chisquared analyses show no differences by race/ethnicity for the reasons to
allow participation [χ² (12) = 16.82, p=.41] or reasons not to allow
participation [ χ² (15) = 25.39, p=.19].
To identify potential predictors for allowing participation, the
significant predictors of the full model were retained in a final reduced
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multivariable multinomial model that fit the data more parsimoniously than
the full exploratory model (AICReduced=1,913.35 vs. AICFull=1,941.39;
BICReduced=2,002.68 vs. BICFull=2,199.47).
The independent variables in the reduced model included the child’s
race/ethnicity, the respondent’s sex, whether the child was reported to be
limited in ability to engage in normal activities due to any condition, child’s
weight, and the difficulties in accessing health care sum score. All results
for the multinomial models are reported based on the reduced model.
Weighted odds ratios and 95% CIs of the contributions of the
predictors from the reduced multivariate multinomial model to the
willingness to participate in clinical research are represented in Figure 1.
Using Non-Hispanic White (NHW) caregivers as the reference group, there
were no differences in the likelihood to allow participation among Hispanic
caregivers. Interestingly, in Non-Hispanic Black (NHB) caregivers, there
was a statistical difference between “very likely” to allow participation
relative to “somewhat likely” when compared with NHW caregivers. In
respondents classified as another race/ethnicity, there was a statistical
difference between “somewhat likely” to allow participation relative to
“unlikely.” Overall, males appeared to be more likely to allow participation
than females. “Child health care access difficulties” in the past 12 months
were consistently associated with a response of being “very likely” to allow
participation and “somewhat likely” to allow participation. Similarly, “child’s
limited ability to do things due to a health condition” was associated with
“very likely” and “somewhat likely” responses to allow participation. In
general, respondents who reported that their child was underweight (vs.
normal weight status) were more likely to allow clinical trial participation,
whereas respondents of children who were overweight relative to normal
weight did not differ in likelihood of allowing participation.
Figure 2 shows adjusted marginal probability estimates for the
variables in the reduced final multinomial model. Even when adjusting for
other factors, the marginal probability for most predictors was highest for
being “Not at all likely” to allow participation (0.32 to 0.60). In contrast,
across all predictors, the lowest adjusted probability was observed among
the “Very likely to allow participation” respondents (0.07 to 0.23).
Noteworthy is the observation that those respondents who reported their
child had a health condition that limited the child’s ability were also
respondents who had a higher adjusted marginal probability of saying that
they would be “Somewhat likely to allow participation” (0.42), which is higher
than the adjusted marginal probability for being “Not at all likely” to allow
participation (0.32) if the child had a health condition. In addition, the
number of health care access difficulties reported by caregivers was related
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to the likelihood of participation (Figure 3). The higher the number of health
care access difficulties reported, the more likely the caregiver was to allow
participation in clinical research.
Discussion
This study was designed to explore the role of different factors in
promoting participation or preventing caregivers from allowing children to
participate in clinical studies and to identify potential predictors for the
willingness to participate. The results show that there are different reasons
why caregivers will allow or reject their child’s participation in clinical
research, which include the sex of the participant, access to health care,
race of the responder, and child’s weight status. Our findings reflect the
complex etiology underlying the participation of children in clinical research.
Aspects related to the design of the study, cultural differences, and
linguistic barriers have been shown to limit participation of minorities in
clinical investigations.2 Our results suggest that the factors and motivators
influencing caregiver decisions about allowing their child to participate in
clinical research differ according to race/ethnic classification. NHB
caregivers were more receptive to allowing participation, an observation
contrary to previous reports of minorities’ lack of willingness to participate
in clinical research opportunities but in line with reports of minorities willing
to but not asked to participate.5,11,12 Although minority participation in clinical
trials is complex, increased receptivity for participation may be a
consequence of recent initiatives targeted to create awareness of the need
for community networks to improve minority health, potentially combined
with the altruistic commitment of minorities to find medical treatment for their
communities.13,14 From this perspective, recruitment efforts to increase
minority participation might need to be strategically marketed as
educational campaigns to create awareness of health as a social and
collective responsibility.
There appears to be a gender disparity regarding caregivers’
willingness to allow their child to participate in clinical research. Male
caregivers are more likely to allow participation (15%) compared to female
caregivers (7%). The weight status of the child also appears to influence
willingness to participate. Interestingly, probability estimates showed a
greater disposition toward research participation among caregivers of
children with underweight status and a greater aversion to participation
among caregivers of children perceived to be within normal weight.
Our data indicate that respondents whose child had a health
condition that limited his/her ability were more willing to participate in
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research and less willing to refuse participation. Also, the adjusted marginal
probability of those who are very or somewhat likely to participate increases
as the number of health care access difficulties increases (Figure 3).
Although research has shown that exposure to medical treatment or having
the disease addressed by a clinical trial increases participation, our data
suggest that parents might view a clinical study as a health care treatment
option.4,15 Parents tend to weigh risks and benefits when considering
children’s participation in clinical research and are motivated by the
opportunity to access new treatments, healthcare professionals, and health
information.16 However, the observation that pediatric research participation
is influenced by the health of the child raises concerns about the
generalizability of the results of that research when health-biased samples
are used to provide overall recommendations to the pediatric population.
It is noteworthy that no differences were observed in the motivators
for clinical research participation between NHW and Hispanics. This finding
is inconsistent with national estimates of Hispanic participation in clinical
trials.17,18 A potential explanation for this discrepancy may be related to
regional variation of social structures and the role Hispanics play in the local
communities.19 In Miami-Dade County, Hispanics make up close to 70% of
the population and are widely integrated into the social, political, and cultural
fabric of the community. It is possible that this local environment contributes
to the similarities noted between the responses of NHW and Hispanics in
this study. These findings might inform future strategies directed toward
reducing the gap in clinical research representation of minority populations,
such as creating awareness among communities and considering health
care access, race of the responder, and other variables. In addition, our
findings underscore the need for future studies that account for the
socioeconomic, political, and cultural diversity of Hispanic and other
minority populations.
As in any population study, some limitations must be recognized.
Foremost, the data utilized for this study was based on a survey whose
original purpose was not directed toward understanding clinical research
participation willingness, and the questions utilized in this survey were not
designed to be used as a research tool for such. Consequently, the creation
of categories capturing those potential motivators influencing clinical
research was arbitrary and relied on the creativity, clinical experience, and
consensual integrity of the investigators. The benefits of having a
representative sample of the population of Miami-Dade, Broward, and Palm
Beach counties were also clouded by the limitations of a sample size that
became diluted when categorized by reasons for participation and
racial/ethnic categories. The limited sample size, combined with the
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laborious statistical approach, impaired the evaluation of potential
interactions between and among predictors, including relationships
between poverty levels and racial/ethnic categories. As a result, the
exploration of such interactive terms was not included in the analyses. Even
though this sample is representative, the self-selection of the caregivers to
participate may limit the participation of those who are distrustful of research
and who, in turn, are unlikely to allow their child to participate in a clinical
trial. It is most important to state that, despite the limitations in the
experimental design of the study, the importance of the results of this
investigation cannot be minimized, particularly when understanding the
need to increase pediatric participation in clinical research. The
thoroughness of our statistical methodology and overall scientific approach
to address our objective serve as evidence of the scientific rigor of our
research team and our commitment to improve public health initiatives that
can be inclusive of all.
From the perspective that clinically applied research will inform and
improve health outcomes for all segments of the population, our findings
raise awareness of the complex and multifactorial nature of engaging
children of diverse backgrounds in clinical research participation and of the
challenges faced by public health initiatives when trying to translate
research findings into policies and treatments that might fail to be applicable
to all.20 Further research into the development of strategies for participatory
research engagement of all sectors of the population seems paramount in
order to implement preventive and treatment strategies that are culturally
and biologically sensitive, fair, and equitable to all segments of the pediatric
population.
Ethical Approval: All procedures performed in studies involving human
participants were in accordance with the ethical standards of the institutional
and/or national research committee and with the 1964 Helsinki declaration
and its later amendments or comparable ethical standards.
Conflict of interest: No authors report a conflict of interest.
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Table 1. Survey weighted estimates of background demographic
characteristics of children in a sample of residents in South Florida, 2015.
Variable
Child age (y)

Child sex
Child
Race/ethnicity

Child insurance
status

Child has usual
source of care
HHS poverty status

Household
language

Caregiver
education level

Child’s weight
status

4/Under
5 to 12
13 to 17
Male

Level

N*
352
409
295
540

Proportion (95% CI)
33.33% (29.79% - 36.87%)
38.72% (35.42% - 42.02%)
27.94% (25.08% - 30.80%)
51.13% (47.67% - 54.59%)

Female
Non-Hispanic White (NHW)

516
286

48.87% (45.41% - 52.33%)
27.08% (24.44% - 29.72%)

Hispanic
Non-Hispanic Black (NHB)
Other race/ethnicity
Private health insurance

445
253
71
496

42.18% (38.74% - 45.62%)
23.98% (20.69% - 27.27%)
6.76% (4.94% - 8.58%)
46.95% (43.55% - 50.35%)

Medicaid or Medicare
Uninsured
Other
Yes

396
85
79
869

37.49% (33.92% - 41.06%)
8.05% (6.08% - 10.02%)
7.50% (5.59% - 9.41%)
82.28% (79.49% - 85.07%)

No
200% of poverty or higher
100% to 199% of poverty

187
600
238

17.72% (14.93% - 20.51%)
56.77% (53.16% - 60.38%)
22.56% (19.69% - 25.43%)

Below poverty
English

218
855

20.67% (17.00% - 24.34%)
80.90% (78.01% - 83.79%)

Spanish
Other
Postgraduate

140
61
184

13.25% (10.69% - 15.81%)
5.85% (4.19% - 7.51%)
17.43% (15.11% - 19.75%)

College graduate
Some college/technical
school
High school or less
About the right weight

323
347

30.59% (27.54% - 33.64%)
32.88% (29.53% - 36.23%)

201
767

19.10% (16.08% - 22.12%)
72.61% (69.52% - 75.70%)

Overweight
147
13.98% (11.60% - 16.36%)
Underweight
141
13.41% (11.03% - 15.79%)
*N values are based on the rounded weighted estimates after imputation
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Table 2. Responses to the question “In general, how likely would you be to
allow your child to participate in a clinical research trial?” Answers are
provided for unweighted and weighted estimates in a sample of residents in
South Florida, 2015.
Unweighted
Level
Not at All
Likely
Somewhat
Likely
Very Likely

Weighted

N

Percent

N

Percent (CI)

584

55.25%

570

53.94% (50.47% - 57.41%)

350

33.11%

367

34.73% (31.41% - 38.05%)

105

9.93%

119

11.32% (9.02% - 13.62%)
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Table 3. Unweighted and weighted percent estimates of identified reasons
to participate or not participate among respondents in a sample of residents
in South Florida, 2015.

Reasons to
Participate

Reasons Not to
Participate

Level

Unweighted

Weighted

N
477

Percent
51.40%

N
466

139

14.98%

128

50
56

5.39%
6.03%

43
54

Percent
50.84% (47.15% 54.54%)
13.93% (11.51% 16.36%)
4.69% (3.20% - 6.18%)
5.87% (4.19% - 7.56%)

106

11.42%

111

12.03% (9.57% - 14.49%)

Don’t know/Not sure

100

10.78%

116

12.63% (9.96% - 15.29%)

Child current health

88

11.13%

88

10.87% (8.45% - 13.29%)

Child future health

52

6.57%

51

6.30% (4.41% - 8.18%)

Science

157

19.85%

146

Other

404

51.07%

408

Unsure

90

11.38%

115

18.10% (15.13% 21.06%)
50.60% (46.59% 54.60%)
14.14% (11.04% 17.23%)

Fear or concern over
study
Need more information
to decide
Inconvenience
Potential lack of health
benefit
Other
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Figure 1. Multinomial model estimates according to race/ethnicity, sex,
child limited ability due to health condition, and child weight status in a
sample of residents in South Florida, 2015.

Multinomial odds ratios (circles) and 95% CIs (black error bars) show the magnitude of
effects of each covariate in the final model. 95% CI bars that do not cross the red line at
1.00 can quickly be identified as statistically significant. The OR and associated 95% CI for
each multinomial outcome contrast are also listed to the right of the visual effects.
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Figure 2. Adjusted marginal probability estimates and 95% CI according to
child’s race/ethnicity, sex, limited ability due to health condition, and weight
status in a sample of residents in South Florida, 2015.
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Figure 3. Health care access difficulties and participation in a sample of
residents in South Florida, 2015.
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